Dicerna Pharmaceuticals shows prevailing Real Value of $18.02 per share. The current price of the firm is $14.43. At this time the firm appears to be undervalued. This module computes value of Dicerna Pharmaceuticals from reviewing the firm fundamentals such as Operating Margin of
(750.62)%, Shares Outstanding of 68.36M and Current Valuation of 656.13M as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we advise to go long with undervalued instruments and to sell out overvalued instruments since at some point assets prices and their ongoing real values will submerge.
September 20, 2019
Dicerna Pharmaceuticals is slightly risky asset. Calculation of real value of Dicerna Pharmaceuticals is based on 3 months time horizon. Increasing Dicerna Pharmaceuticals time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Valuation Drivers Correlation
|Click cells to compare fundamentals||View All Correlations|
Dicerna Pharmaceuticals Market CapDicerna Pharmaceuticals is rated # 4 in market capitalization category among related companies. Market capitalization of Biotechnology industry is currently estimated at about 5.51 Billion. Dicerna Pharmaceuticals retains roughly 979.6 Million in market capitalization claiming about 18% of stocks in Biotechnology industry.
|Horizon||30 Days Login to change|
Dicerna Pharmaceuticals is rated below average in price to book category among related companies. It is rated below average in price to earning category among related companies .
|Price to Book ( times )|
|Price to Earning ( times )|